AdvaMed Submits Comments on CY 2023 ESRD PPS Proposed Rule
AdvaMed submitted comments to CMS the CY 2023 End Stage Renal Disease (ESRD) Prospective Payment System.
Resource Library
Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
Filter By:
AdvaMed Submits Comments on Genetic Testing in Oncology LCD
AdvaMed submitted a letter to Medicare Administrative Contractors, Novitas and First Coast Service Options, regarding proposed LCDs on Genetic Testing in Oncology.
AdvaMed Submits Comments on FY 2023 IPPS Proposed Rule
AdvaMed submitted comments to CMS on the Fiscal Year 2023 Hospital Inpatient Prospective Payment System proposed rule.
AdvaMedDx COVID Testing Supply Retrospective Report
This report examines cumulative data from the first two years of the COVID Test Registry to demonstrate the mobilization of the diagnostics industry over the course of the pandemic.
AdvaMed Comments on Proposed Delay of Radiation Oncology Model
AdvaMed submitted comments to the Center for Medicare and Medicaid Services (CMS) on its Radiation Oncology (RO) Model proposed rule proposing to indefinitely delay the start date of the RO…
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, MedTech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed Submits Comments on Local Coverage Determination of Skin Substitutes
AdvaMed submitted a letter regarding proposed local coverage determinations entitled “Skin Substitutes for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcer.”
Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities
Based on insights from a related workshop series, this document outlines potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.
The VALID Act Sponsor Prepared Summaries And Fact Sheets
Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.
